Patent · US Active

Chronic treatment regimen using glucagon-like insulinotropic peptides

US7989585B2 · kind B2 · utility

15Cited by

1References

4Claims

0Family size

Assignee

ELI LILLY AND COMPANY · US

Inventors

Steven Witt Dodd · Zionsville, US
Kenneth Francis Mace · Fishers, US
Michael Trautmann · Neudrossenfeld, DE

Key dates

Filing date	Aug 10, 2007
Grant date	Aug 2, 2011
Priority date	—
Expiry date	Mar 8, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention encompasses a method of treating a disease by maintaining chronic steady state serum levels of a GLP-1 compound within a specified range.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.